Skip to main content

Table 5 Accompanying Figure 2

From: Association between genomic recurrence risk and well-being among breast cancer patients

 

Distress

Worry

Quality of life

 

Mean (95% CI)

Mean (95% CI)

Mean (95% CI)

C-low/G-low

1.52 (1.42 to 1.62)

1.73 (1.63 to 1.84)

28.0 (27.1 to 28.9)

C-high/G-high

2.39* (2.21 to 2.56)

1.82 (1.69 to 1.95)

25.6* (24.4 to 26.9)

C-low/G-high (assigned to no CT)

2.03* (1.64 to 2.41)

1.77 (1.41 to 2.14)

28.0 (24.9 to 31.1)

C-low/G-high (assigned to CT)

2.71* (2.35 to 3.07)

1.72 (1.40 to 2.05)

26.3 (23.6 to 29.0)

C-high/G-low (assigned to no CT)

2.11* (1.70 to 2.52)

1.85 (1.61 to 2.10)

26.9 (24.6 to 29.1)

C-high/G-low (assigned to CT)

1.68 (1.45 to 1.91)

1.49 (1.34 to 1.65)

26.9 (25.1 to 28.8)

C-low/G-na

1.95* (1.58 to 2.32)

1.86 (1.61 to 2.10)

26.0 (23.9 to 28.2)

C-high/G-na

2.31* (2.11 to 2.51)

1.95 (1.80 to 2.11)

23.8* (22.5 to 25.2)

  1. Note. The reference group in analyses was C-low/G-low. C, clinical, G = genomic, CT, chemotherapy, na, result not available. n = 347.
  2. *p < 0.01.